Normally I do not read business pages - but this is interesting for our scientific field.
CNNMoney.com writes on the business outlook of
Cyberonics for the depression indication. Overall the future does not seem too bright right now:
The need for a trial, plus the need to convince insurers, suggests it could take years before the depression business has a chance to speed up, said analyst Brozak, who has a sell rating on Cyberonics. In today's financial markets, that is a long and uncertain investment horizon for potential partners, he said.